This supplement is based on two symposia sponsored by Glaxo Wellcome. The first was on Monotherapy and Polytherapy in Epilepsy held at the 32nd Canadian Congress of Neurological Sciences in Saskatoon, Saskatchewan in June, 1997. The second was a continuing medical education program for neurologists on epilepsy held at Glaxo Wellcome offices in Mississauga, Ontario in September, 1997.

SUPPLEMENT

Monotherapy or Polytherapy for Epilepsy
Alan Guberman  

Monotherapy versus Polytherapy in Epilepsy: a Framework for Patient Management
JH Schneiderman

Rash in Adult and Pediatric Patients Treated with Lamotrigine
John A Messenheimer

Women's Issues in the Treatment of Epilepsy
J Bruni

Consequences of Epilepsy: Why do We Treat Seizures?
Michael W Jones 

The Canadian Epilepsy Database and Registry
RS McLachlan